Aktis Oncology Shares Surge Over 5% on First Trading Day
With the first biotech IPO of the year, Aktis Oncology blew past expectations, with shares jumping on the first day of trading.LATEST IPOS AND DIRECT LISTINGS:Aktis Oncologyopened on January 9 at $27. The clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations priced its upsized initial public offering of 17.65M shares of its common stock at a price to the public of $18.00 per share. The deal priced at the high-end of the $16.00-$18.00 range.Buda Juiceopened on January 8 at $12. The company priced its initial public offering of 2,666,667 shares of its common stock at the public offering price of $7.50 per share. The deal priced at the low end of its $7.50-$9.00 range. Buda Juice intends to use the net proceeds from the offering to develop and build production plants in South Carolina and Arizona/Nevada, expand capacity in its Dallas production plant, support in-store marketing and provide working capital for its expansion of its freshly crafted juices, lemonades, and wellness shots to grocery retailers.RECENT SPAC IPOS:Lafayette Digital Acquisition Iopened on January 9 at $10.01. The blank check company had priced its initial public offering of 25M units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments.Bleichroeder Acquisition IIopened on Jnauary 8 at $10.03. The blank check company may pursue an acquisition opportunity in any industry, sector or geographic region. The company's primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption.Soren Acquisitionopened on January 7 at $10. The blank check company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution, but is focused on completing a business combination with "an attractive target business within the healthcare industry".Black Spade Acquisition IIIopened on January 6 at $9.97. The special purpose acquisition company is sponsored by an affiliate of Black Spade Capital Limited.PERFORMANCE:Prices as of 11 am ET on Monday, January 12 -Aktis Oncology – up over 5% at $23.53;Buda Juice – up almost 2% at $8.31.RECENT IPOS TO WATCH:Medlineand Andersen Groupare already seeing coverage roll out, while Starfighters Spaceis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include PicS N.V., Grayscale, Klook, Speed Group, and Lendbuzz.Clickto see upcoming IPO calendar on TipRanks.PicS N.V.filed for an initial public offering of Class A common shares, which it intends to apply to list on the Nasdaq Global Select Market under the symbol "PICS." The company said it will not seek a listing for its Class B common shares on Nasdaq or on any other exchange. The filing stated, "PicPay Netherlands, the company whose Class A common shares are being offered in this prospectus, was incorporated on December 27, 2023, as a private limited liability company under Dutch law, with its corporate seat in Amsterdam, the Netherlands, with the name 'Picpay Holdings Netherlands B.V.' Prior to the closing of this offering, the issuer will be converted into a public limited liability company under Dutch law with the name 'PicS N.V.'... At PicPay, we believe financial services should be mobile, frictionless, and instantaneous. Our mission is to empower consumers and businesses across Brazil with innovative solutions to redefine the way people manage their traditional daily finances. We break down the barriers to traditional financial services and are driven by a vision of a future where financial services are accessible for all. We are committed to simplifying financial transactions, fostering economic inclusion and providing the tools and resources for people to achieve their financial goals."GrayscaleInvestments filed a prospectus for an initial public offering on the New York Stock Exchange under the ticker symbol "GRAY." Grayscale says it is the largest digital asset-focused investment platform in the world, with $35B in assets under management as of September 30. "Our mission is to make digital asset investing simple and open to every investor. Founded in 2013, we have pioneered regulated access to the digital asset class. Our platform spans the full spectrum of institutional-grade solutions, providing investors with the broadest and most diverse suite of digital asset-focused investment products in the United States based on number of products," the company added.Klook Technology, which identifies itself as "the largest pan-regional experiences platform in Asia-Pacific" by gross transaction volume in 2024, announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of American Depositary Shares representing its ordinary shares. The company has applied to list the ADSs on the New York Stock Exchange under the ticker symbol "KLK". The number of ADSs to be offered and the price range for the proposed offering have not yet been determined.Speed Groupfiled a prospectus for 2.5M share initial public offering. It expects the IPO price to be in the range of $4.00 to $5.00 per. The company's operating subsidiary, Speed Logistics, is an e-commerce logistics provider providing end-to-end logistics solution in Hong Kong, Europe and North America. The services include warehousing, customs clearance, air transportation, and final delivery from the European airports. For the years ended June 30, 2024 and 2025, Speed's revenues were $17.9M and $22.64M, respectively.Lendbuzz Inc.is offering an undetermined number of shares of its common stock and the selling stockholders identified in this prospectus are offering additional shares of common stock, according to an initial public offering prospectus filed with the SEC. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "LBZZ." The prospectus states: "Our mission is to offer fair access to credit for underserved populations. We are a financial technology company that utilizes artificial intelligence, or AI, and machine learning algorithms to better assess consumer credit risk and expand access to credit. We seamlessly process large sets of data through advanced computational approaches to more accurately predict a consumer's creditworthiness. Our business benefits both consumers through expanded access to credit, and auto dealerships via increased vehicle sales."OTHER IPO NEWS:Construction equipment rental firm EquipmentShare.com, which filed publicly for a listing on December 9, may begin formal marketing for its initial public offering as soon as next week and could raise about $1B, a person familiar with the matter told Bloomberg's Bailey Lipschultz and Anthony Hughes. Motive Technologies, which makes artificial intelligence-enabled fleet management software and filed its IPO paperwork publicly on December 23, may also begin formal marketing next week as it seeks to raise around $600M, the report noted that a person with knowledge of the deal said."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on MDLN
About MDLN
About the author

- Strategic Partnership: Medline has entered into a strategic agreement with AI robotics leader Symbotic to pilot next-generation warehouse automation technology in one of its 45 U.S. distribution centers in 2027, aiming to enhance the resilience and efficiency of the healthcare supply chain, thereby strengthening its competitive position in the medical industry.
- Innovative Technology Application: The Symbotic system automates the picking, storage, and retrieval of items using intelligent autonomous robots, enabling rapid processing of inbound full pallets and constructing smart outbound pallets tailored to downstream needs, which is expected to significantly boost Medline's distribution speed and operational efficiency.
- Enhanced Customer Service: Medline's Chief Supply Chain Officer, Sean Halligan, stated that this investment will help customers achieve higher operational, clinical, and financial goals, further solidifying Medline's leadership in medical products and supply chain solutions.
- Ongoing Technology Investment: This partnership is part of Medline's continued investment in advanced technologies across its U.S. distribution center network, aimed at improving speed, accuracy, and scalability while enhancing employee safety and experience, ensuring the company maintains a competitive edge in a rapidly changing market.
- Technology Launch: On April 6, Medline launched Pick Pack Pro at its Montgomery, NY distribution center, a new custom fulfillment technology that integrates robotic sortation, conveyor movement, and automated packing to deliver medical supplies directly to health plan members' homes.
- Demand Management: This system is specifically designed to handle high-volume spikes for select product catalogs, such as over-the-counter medications and everyday medical essentials, enhancing delivery speed and order accuracy through partnerships with Tompkins Robotics, Trew, and Ranpak.
- Industry Leadership: Sean Halligan, Medline's executive vice president of operations, emphasized that this solution positions Medline as an industry leader in addressing fulfillment challenges specific to the health plan sector, further solidifying its market position.
- Expansion Plans: The Montgomery installation represents Medline's initial capital and staffing investment in this specialized technology, with plans to deploy Pick Pack Pro across its broader network of 45 distribution centers in the US, expected to significantly enhance overall operational efficiency.
- Regulatory Warning: The FDA has warned Medline (MDLN) of potential regulatory action due to violations in the production of its NAMIC Angiographic Control Syringes, which could harm the company's reputation and market trust.
- Production Violations: In a letter dated March 25, the FDA highlighted that Medline failed to take adequate measures following a December 2022 inspection, resulting in 221 complaints and 177 safety reports, indicating severe deficiencies in production management.
- Product Defects: Complaints surged in June 2023 due to device failures attributed to excess silicone, with the FDA stating that Medline's risk assessment did not align with its design failure modes analysis, reflecting negligence in product safety.
- Market Reaction: Although Medline pledged to withdraw the defective devices from the market in February, the FDA has mandated a response within 15 business days, warning that failure to adequately address the issues may lead to financial penalties, potentially impacting stock prices and investor confidence.
- Earnings Announcement: Medline Inc. has announced that it will report its Q1 2026 financial results on May 6, 2026, and will host a webcast and conference call to discuss the financial performance, which is expected to provide critical performance data for investors.
- Market Transparency: Prior to the earnings release, the company will issue a press release and supplemental materials before the market opens, ensuring that investors can access relevant information in a timely manner, thereby enhancing market transparency.
- Company Overview: Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care, employing over 45,000 people and operating in more than 100 countries, demonstrating its extensive influence in the healthcare sector.
- Investor Relations: The company will provide detailed information about its financial results and a link to the webcast on its Investor Relations website, ensuring that investors can easily access replay content, further improving communication efficiency with stakeholders.
- Automated Fulfillment System: Medline has launched the Pick Pack Pro™ automated system at its Montgomery, NY distribution center, marking a significant investment in advanced automation to support the needs of health plan customers.
- Order Processing Optimization: The system addresses the challenges of delivery timeliness and accuracy during peak fulfillment periods for health plan orders by integrating optimized order batching, robotic sortation, and automated packing, which is expected to significantly enhance customer satisfaction and care outcomes.
- Partnership Development: Medline collaborated with key vendors including Tompkins Robotics, Trew, and Ranpak to develop this system, leveraging their technologies for efficient sorting and packaging of order items, showcasing the company's leadership in the medical supply chain sector.
- Expansion Plans: Medline intends to deploy the Pick Pack Pro system across its network of 45 distribution centers in the U.S., further enhancing its service capabilities to meet the growing demands of the health plan market.
- Automation Investment: Medline has launched the Pick Pack Pro™ system at its Montgomery, NY distribution center, marking a significant investment in advanced automation aimed at enhancing the delivery efficiency of medical supplies, particularly for health plan customers.
- Order Processing Optimization: The system integrates optimized order batching, robotic sortation, and automated packing to address the challenges of delivery times and accuracy during peak fulfillment periods, thereby improving customer satisfaction and overall care outcomes.
- Partnership Development: Medline collaborated with three key vendors—Tompkins Robotics, Trew, and Ranpak—to develop this system, ensuring efficient sorting of order items and sustainable packaging solutions, which underscores the company's leadership in the medical supply chain sector.
- Expansion Plans: Medline intends to deploy the Pick Pack Pro system across its network of 45 distribution centers in the U.S., further enhancing its competitiveness in the medical supply market and meeting the growing demands of its customers.









